Quote | Mallinckrodt plc (OTCMKTS:MNKKQ)
Last: | $0.02 |
---|---|
Change Percent: | 10.5% |
Open: | $0.0181 |
Close: | $0.02 |
High: | $0.0248 |
Low: | $0.0173 |
Volume: | 290,539 |
Last Trade Date Time: | 06/16/2022 04:37:31 am |
News | Mallinckrodt plc (OTCMKTS:MNKKQ)
MALLINCKRODT TO REPORT EARNINGS RESULTS FOR SECOND QUARTER 2022 AND PROVIDE BUSINESS UPDATE PR Newswire DUBLIN , Aug. 3, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, announced today that it wil...
Mallinckrodt Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Financial Flexibility PR Newswire Appoints Sigurdur Olafsson as President and Chief Executive Officer DUBLIN, Ireland , June 16, 2022 /PRNewswire/ -- Mallinckr...
Message Board Posts | Mallinckrodt plc (OTCMKTS:MNKKQ)
Subject | By | Source | When |
---|---|---|---|
mdanese: Judge John Dorsey issued an oral ruling sustaining the Mallinckrodt debtors objections to t | mdanese | investorshangout | 12/07/2021 9:47:03 PM |
znewcar1: MNKKQ 67% v8,7M c.39 f84,6M H.04 mooring push to .4 S@.27 | znewcar1 | investorshangout | 01/27/2021 9:33:55 PM |
znewcar1: MNKKQ 58% v6,1M c.4150 f84,6M H.041 | znewcar1 | investorshangout | 12/15/2020 9:40:22 PM |
znewcar1: MNKKQ 28% v3,1M c.333 f84,6M H.36 | znewcar1 | investorshangout | 12/10/2020 10:01:59 PM |
znewcar1: MNKKQ 43% v3,8M c.26 f84,6M H.5 S.25 crazy pop and back | znewcar1 | investorshangout | 12/09/2020 9:51:31 PM |
News, Short Squeeze, Breakout and More Instantly...
Mallinckrodt plc Company Name:
MNKKQ Stock Symbol:
OTCMKTS Market:
MALLINCKRODT TO REPORT EARNINGS RESULTS FOR SECOND QUARTER 2022 AND PROVIDE BUSINESS UPDATE PR Newswire DUBLIN , Aug. 3, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, announced today that it wil...
Mallinckrodt Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Financial Flexibility PR Newswire Appoints Sigurdur Olafsson as President and Chief Executive Officer DUBLIN, Ireland , June 16, 2022 /PRNewswire/ -- Mallinckr...
Mallinckrodt Announces Resubmission of Terlipressin to the FDA for the Treatment of Hepatorenal Syndrome PR Newswire DUBLIN , June 13, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced the ...